Pictet Asset Management (Switzerland)’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
BI
RG
CS
PA
RCMNY
Pictet Asset Management (Switzerland)'s ZYME Position: Q2 2023 in Review
Pictet Asset Management (Switzerland) sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 14,669 shares — an estimated $133K sold.
Pictet Asset Management (Switzerland) first reported a position in ZYME in Q3 2021 and held it in 2 quarters. The position peaked at $51.3M in Q3 2021. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.
- Pictet Asset Management (Switzerland) reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
- Pictet Asset Management (Switzerland) sold 14,669 Zymeworks shares in Q2 2023, an estimated $133K.
- Pictet Asset Management (Switzerland) first reported a position in Zymeworks in Q3 2021 and held it in 2 quarters.
- Pictet Asset Management (Switzerland)'s Zymeworks position peaked at $51.3M in Q3 2021.
- 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.